Skip to content

Casdin Capital, LLC

Follow

13F filer, CIK 1534261, New York, NY

Casdin Capital, LLC reported $2,295,707,123 across 48 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 76.12% of the portfolio.

Accepted , ingested 13F-HR 0000919574-26-008113

Period
2026-09-30
Reported value
$2.3B
Holdings
48
Top 10 weight
76.12%
New
7
Sold out
2

Largest buys vs the previous quarter

SecurityShares changeApprox. value
TEMnew+423,597$34.7M
GRALadded+200,000$28M
SRPTadded+1,350,000$24.6M
ORICnew+1,250,000$16.8M
BIIBnew+50,000$11.3M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
SIONexited-400,000-$17.6M
DNLIreduced-795,000-$16.4M
BLFSreduced-155,000-$6.02M
IRONexited-65,000-$4.75M
GPCRreduced-145,000-$4.53M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0000919574-26-008113, largest first. % of portfolio is the value over $2,295,707,123, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,699,283 shares; 2025Q1: 3,697,933 shares; 2025Q2: 2,887,933 shares; 2025Q3: 2,647,333 shares; 2025Q4: 2,577,333 shares; 2026Q1: 2,577,333 shares; 2026Q2: 2,577,333 shares; 2026Q3: 2,577,333 shares 2,577,333$529M23.04%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,948,574 shares; 2025Q1: 9,098,574 shares; 2025Q2: 11,398,574 shares; 2025Q3: 11,341,381 shares; 2025Q4: 13,003,574 shares; 2026Q1: 14,418,574 shares; 2026Q2: 16,035,240 shares; 2026Q3: 16,035,240 shares 16,035,240$289M12.61%0Timeline
WGSGENEDX HOLDINGS CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 3,507,164 shares; 2025Q1: 3,507,164 shares; 2025Q2: 3,507,164 shares; 2025Q3: 3,007,164 shares; 2025Q4: 3,007,164 shares; 2026Q1: 3,007,164 shares; 2026Q2: 3,707,164 shares; 2026Q3: 3,707,164 shares 3,707,164$268M11.68%0Timeline
BLFSBIOLIFE SOLUTIONS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 8,707,165 shares; 2025Q1: 8,707,165 shares; 2025Q2: 7,707,165 shares; 2025Q3: 6,707,165 shares; 2025Q4: 5,957,165 shares; 2026Q1: 5,957,165 shares; 2026Q2: 4,655,000 shares; 2026Q3: 4,500,000 shares 4,500,000$175M7.62%-155,000Timeline
ILMNILLUMINA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 750,000 shares; 2025Q1: 595,000 shares; 2025Q2: 645,000 shares; 2025Q3: 525,000 shares; 2025Q4: 600,000 shares; 2026Q1: 530,000 shares; 2026Q2: 530,000 shares; 2026Q3: 530,000 shares 530,000$145M6.32%0Timeline
GRALGRAIL INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 230,000 shares; 2026Q2: 480,000 shares; 2026Q3: 680,000 shares 680,000$95.3M4.15%+200,000Timeline
TXG10X GENOMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,400,000 shares; 2026Q1: 2,275,000 shares; 2026Q2: 1,050,000 shares; 2026Q3: 1,050,000 shares 1,050,000$94.9M4.13%0Timeline
LABSTANDARD BIOTOOLS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 71,254,677 shares; 2025Q1: 76,075,636 shares; 2025Q2: 76,075,636 shares; 2025Q3: 77,558,856 shares; 2025Q4: 88,783,856 shares; 2026Q1: 88,783,856 shares; 2026Q2: 88,783,856 shares; 2026Q3: 88,783,856 shares 88,783,856$65.8M2.86%0Timeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,295,361 shares; 2025Q1: 1,295,361 shares; 2025Q2: 1,295,361 shares; 2025Q3: 1,295,361 shares; 2025Q4: 1,295,361 shares; 2026Q1: 1,420,361 shares; 2026Q2: 1,545,361 shares; 2026Q3: 1,585,361 shares 1,585,361$44.1M1.92%+40,000Timeline
SRRKSCHOLAR ROCK HLDG CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 260,000 shares; 2026Q1: 350,000 shares; 2026Q2: 665,000 shares; 2026Q3: 850,000 shares 850,000$41.1M1.79%+185,000Timeline
PSNLPERSONALIS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,600,000 shares; 2026Q2: 2,550,000 shares; 2026Q3: 2,300,000 shares 2,300,000$37.4M1.63%-250,000Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,250,000 shares; 2025Q1: 1,425,562 shares; 2025Q2: 1,450,000 shares; 2025Q3: 1,600,000 shares; 2025Q4: 1,600,000 shares; 2026Q1: 1,350,000 shares; 2026Q2: 1,350,000 shares; 2026Q3: 1,500,000 shares 1,500,000$36.7M1.6%+150,000Timeline
TEMTEMPUS AI INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 294,127 shares; 2025Q4: 294,127 shares; 2026Q1: 294,127 shares; 2026Q2: not reported; 2026Q3: 423,597 shares 423,597$34.7M1.51%newTimeline
SRPTSAREPTA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,073,500 shares; 2025Q1: 900,783 shares; 2025Q2: 990,097 shares; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 470,000 shares; 2026Q3: 1,820,000 shares 1,820,000$33.2M1.44%+1,350,000Timeline
GHGUARDANT HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 350,000 shares; 2025Q1: 250,000 shares; 2025Q2: 100,000 shares; 2025Q3: 100,000 shares; 2025Q4: 380,000 shares; 2026Q1: 315,000 shares; 2026Q2: 185,000 shares; 2026Q3: 185,000 shares 185,000$33M1.44%0Timeline
GPCRSTRUCTURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 700,000 shares; 2025Q1: 700,000 shares; 2025Q2: 1,225,000 shares; 2025Q3: 1,555,000 shares; 2025Q4: 1,175,000 shares; 2026Q1: 1,175,000 shares; 2026Q2: 1,175,000 shares; 2026Q3: 1,030,000 shares 1,030,000$32.2M1.4%-145,000Timeline
ALNYALNYLAM PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 140,000 shares; 2025Q1: 120,000 shares; 2025Q2: 81,500 shares; 2025Q3: 55,000 shares; 2025Q4: 75,000 shares; 2026Q1: 75,000 shares; 2026Q2: 75,000 shares; 2026Q3: 120,000 shares 120,000$29.6M1.29%+45,000Timeline
DNLIDENALI THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 990,000 shares; 2025Q1: 990,000 shares; 2025Q2: 890,000 shares; 2025Q3: 890,000 shares; 2025Q4: 1,840,000 shares; 2026Q1: 1,840,000 shares; 2026Q2: 2,045,000 shares; 2026Q3: 1,250,000 shares 1,250,000$25.8M1.13%-795,000Timeline
HIMSHIMS & HERS HEALTH INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 200,000 shares; 2025Q2: 230,000 shares; 2025Q3: 230,000 shares; 2025Q4: 385,000 shares; 2026Q1: 700,000 shares; 2026Q2: 700,000 shares; 2026Q3: 800,000 shares 800,000$23.8M1.04%+100,000Timeline
MAZEMAZE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: 946,357 shares; 2025Q2: 758,857 shares; 2025Q3: 758,857 shares; 2025Q4: 758,857 shares; 2026Q1: 758,857 shares; 2026Q2: 843,857 shares; 2026Q3: 843,857 shares 843,857$22.9M1%0Timeline
SEPNSEPTERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 553,268 shares; 2025Q1: 553,268 shares; 2025Q2: 553,268 shares; 2025Q3: 553,268 shares; 2025Q4: 553,268 shares; 2026Q1: 553,268 shares; 2026Q2: 553,268 shares; 2026Q3: 553,268 shares 553,268$21.6M0.94%0Timeline
PBLSPARABILIS MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 645,690 shares; 2026Q3: 645,690 shares 645,690$20.8M0.91%0Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 538,461 shares; 2026Q2: 1,250,000 shares; 2026Q3: 1,250,000 shares 1,250,000$20M0.87%0Timeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 1,500,000 shares; 2026Q1: 3,250,000 shares; 2026Q2: 3,250,000 shares; 2026Q3: 3,900,000 shares 3,900,000$19M0.83%+650,000Timeline
AGMBAGOMAB THERAPEUTICS NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 1,550,000 shares; 2026Q2: 1,550,000 shares; 2026Q3: 1,550,000 shares 1,550,000$17.2M0.75%0Timeline
ORICORIC PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,250,000 shares 1,250,000$16.8M0.73%newTimeline
MRNAMODERNA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 175,000 shares; 2025Q1: 225,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 75,000 shares; 2026Q2: 75,000 shares; 2026Q3: 75,000 shares 75,000$14.4M0.63%0Timeline
VCYTVERACYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 276,308 shares; 2025Q1: 276,308 shares; 2025Q2: 276,308 shares; 2025Q3: 276,308 shares; 2025Q4: 276,308 shares; 2026Q1: 276,308 shares; 2026Q2: 276,308 shares; 2026Q3: 276,308 shares 276,308$12.7M0.55%0Timeline
DGXQUEST DIAGNOSTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: 50,000 shares; 2026Q1: 50,000 shares; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000$11.7M0.51%0Timeline
BIIBBIOGEN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 50,000 shares 50,000$11.3M0.49%newTimeline
EWTXEDGEWISE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 265,000 shares 265,000$10.8M0.47%newTimeline
ABSIABSCI CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 973,260 shares; 2025Q1: 973,260 shares; 2025Q2: 973,260 shares; 2025Q3: 973,260 shares; 2025Q4: 973,260 shares; 2026Q1: 973,260 shares; 2026Q2: 973,260 shares; 2026Q3: 973,260 shares 973,260$10.5M0.46%0Timeline
PRMEPRIME MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 367,175 shares; 2025Q1: 367,175 shares; 2025Q2: 1,567,175 shares; 2025Q3: 3,167,175 shares; 2025Q4: 3,167,175 shares; 2026Q1: 3,167,175 shares; 2026Q2: 3,167,175 shares; 2026Q3: 3,167,175 shares 3,167,175$9.68M0.42%0Timeline
BNTXBIONTECH SEQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 85,000 shares 85,000$8.36M0.36%newTimeline
BRVEBRAVEHEART BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 400,000 shares 400,000$8.08M0.35%newTimeline
RAPPRAPPORT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 200,000 shares 200,000$6.72M0.29%newTimeline
NTLAINTELLIA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 2,000,000 shares; 2025Q1: 2,000,000 shares; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: 355,000 shares; 2026Q2: 355,000 shares; 2026Q3: 355,000 shares 355,000$4.28M0.19%0Timeline
QUREUNIQURE NVQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 150,000 shares; 2026Q3: 150,000 shares 150,000$3.62M0.16%0Timeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 5,190,506 shares; 2025Q1: 3,212,316 shares; 2025Q2: 1,228,190 shares; 2025Q3: 1,228,190 shares; 2025Q4: 1,228,190 shares; 2026Q1: 1,228,190 shares; 2026Q2: 1,228,190 shares; 2026Q3: 1,228,190 shares 1,228,190$2.1M0.09%0Timeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 296,666 shares; 2025Q1: 148,333 shares; 2025Q2: 148,333 shares; 2025Q3: 148,333 shares; 2025Q4: 148,333 shares; 2026Q1: 148,333 shares; 2026Q2: 148,333 shares; 2026Q3: 148,333 shares 148,333$1.99M0.09%0Timeline
PACBPACIFIC BIOSCIENCES CALIF INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 1,035,859 shares; 2025Q1: 723,767 shares; 2025Q2: 723,767 shares; 2025Q3: 723,767 shares; 2025Q4: 4,223,767 shares; 2026Q1: 723,767 shares; 2026Q2: 723,767 shares; 2026Q3: 723,767 shares 723,767$1.72M0.07%0Timeline
BBOTBRIDGEBIO ONCOLOGY THERAPEUTQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: 282,312 shares; 2025Q4: 282,312 shares; 2026Q1: 282,312 shares; 2026Q2: 282,312 shares; 2026Q3: 282,312 shares 282,312$1.16M0.05%0Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 445,000 shares; 2026Q3: 445,000 shares 445,000$1.14M0.05%0Timeline
GLUEMONTE ROSA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 86,014 shares; 2025Q1: 86,014 shares; 2025Q2: 86,014 shares; 2025Q3: 86,014 shares; 2025Q4: 86,014 shares; 2026Q1: 186,014 shares; 2026Q2: 186,014 shares; 2026Q3: 86,014 shares 86,014$1.03M0.04%-100,000Timeline
KARDKARDIGAN INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not reported; 2025Q1: not reported; 2025Q2: not reported; 2025Q3: not reported; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 50,000 shares; 2026Q3: 50,000 shares 50,000$738K0.03%0Timeline
RXRXRECURSION PHARMACEUTICALS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 165,323 shares; 2025Q1: 165,323 shares; 2025Q2: 165,323 shares; 2025Q3: 165,323 shares; 2025Q4: 165,323 shares; 2026Q1: 165,323 shares; 2026Q2: 165,323 shares; 2026Q3: 165,323 shares 165,323$683K0.03%0Timeline
DNAGINKGO BIOWORKS HOLDINGS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 36,493 shares; 2025Q1: 36,493 shares; 2025Q2: 36,493 shares; 2025Q3: 36,493 shares; 2025Q4: 36,493 shares; 2026Q1: 36,493 shares; 2026Q2: 36,493 shares; 2026Q3: 36,493 shares 36,493$468K0.02%0Timeline
TNYATENAYA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: 6,732,971 shares; 2025Q1: 6,732,971 shares; 2025Q2: 361,969 shares; 2025Q3: 361,969 shares; 2025Q4: 361,969 shares; 2026Q1: 361,969 shares; 2026Q2: 361,969 shares; 2026Q3: 361,969 shares 361,969$218K0.01%0Timeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
SIONSIONNA THERAPEUTICS INC400,000$17.6Mshares
IRONDISC MEDICINE INC65,000$4.75Mshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000919574-26-008113 base2026-11-16